$ATRS ANTARES PHARMA, INC. Insider Trading Week 27/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANTARES PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANTARES PHARMA, INC. in week 27/2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.07 | 19,598 | 40,501 | 6,213,945 | 6.2 M to 6.2 M (-0.31 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.07 | 24,943 | 51,547 | 7,908,657 | 7.9 M to 7.9 M (-0.31 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.06 | 43,956 | 90,330 | 6,233,543 | 6.3 M to 6.2 M (-0.70 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.06 | 55,944 | 114,965 | 7,933,600 | 8 M to 7.9 M (-0.70 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.05 | 43,956 | 89,890 | 6,277,499 | 6.3 M to 6.3 M (-0.70 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.05 | 55,944 | 114,405 | 7,989,544 | 8 M to 8 M (-0.70 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.06 | 44,000 | 90,420 | 6,321,455 | 6.4 M to 6.3 M (-0.69 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.06 | 56,000 | 115,080 | 8,045,488 | 8.1 M to 8 M (-0.69 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.05 | 44,000 | 89,980 | 6,365,455 | 6.4 M to 6.4 M (-0.69 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.05 | 56,000 | 114,520 | 8,101,488 | 8.2 M to 8.1 M (-0.69 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.10 | 41,650 | 87,369 | 6,409,455 | 6.5 M to 6.4 M (-0.65 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.10 | 53,009 | 111,197 | 8,157,488 | 8.2 M to 8.2 M (-0.65 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.09 | 24,108 | 50,395 | 6,451,105 | 6.5 M to 6.5 M (-0.37 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.09 | 30,684 | 64,142 | 8,210,497 | 8.2 M to 8.2 M (-0.37 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.09 | 2,244 | 4,679 | 6,475,213 | 6.5 M to 6.5 M (-0.03 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.09 | 2,856 | 5,955 | 8,241,181 | 8.2 M to 8.2 M (-0.03 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.09 | 3,476 | 7,247 | 6,477,457 | 6.5 M to 6.5 M (-0.05 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.09 | 4,424 | 9,224 | 8,244,037 | 8.2 M to 8.2 M (-0.05 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.08 | 15,928 | 33,130 | 6,480,933 | 6.5 M to 6.5 M (-0.25 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.08 | 20,272 | 42,166 | 8,248,461 | 8.3 M to 8.2 M (-0.25 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.12 | 67,577 | 143,371 | 6,496,861 | 6.6 M to 6.5 M (-1.03 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.12 | 86,007 | 182,472 | 8,268,733 | 8.4 M to 8.3 M (-1.03 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.12 | 16,689 | 35,362 | 6,564,438 | 6.6 M to 6.6 M (-0.25 %) |
Jul 08 2015 | ATRS | ANTARES PHARMA, IN ... | Flynn James E | 10% Owner | Sell | S | 2.12 | 21,240 | 45,005 | 8,354,740 | 8.4 M to 8.4 M (-0.25 %) |